WEST PALM BEACH, FL & EXTON, PA — ProRx Pharma has announced the addition of six injectable products to its portfolio, aimed at supporting the growing demand for preventive care. The new offerings include Gonadorelin, Liraglutide, Vitamin D3, Phenylephrine HCl, and two Tri-Mix options, addressing diverse health needs such as fertility, weight management, hormonal balance, and erectile dysfunction (ED).
Available for bulk shipping to licensed facilities in 26 states and direct-to-consumer shipping nationwide, these formulations feature National Drug Code (NDC) numbers and extended Beyond Use Dates (BUD), enhancing flexibility and storage capabilities for providers.
“Patients are taking charge of their health like never before,” said ProRx Chief Operating Officer Kurt Lunkwitz. “Physicians are following suit, integrating wellness therapies into their practices to meet the demand for more proactive, functional care. This trend is only going to continue. The continued expansion of our health and wellness line is a direct response—and a step toward making preventative health more accessible and streamlined.”
Among the new offerings, Gonadorelin supports hormonal balance and fertility, while Liraglutide aids in weight management and blood sugar control. Vitamin D3 addresses severe deficiencies, benefiting bone health and immune function. The Tri-Mix injections target ED with varying strengths, while Phenylephrine HCl offers a safety option to counteract priapism associated with ED therapies.
This launch comes shortly after ProRx introduced four preventative-care products earlier in April, continuing its commitment to providing accessible wellness solutions for patients and healthcare providers.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.